A clinical trial has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, ...

Opportunities in the North America molecular diagnostics market include rising demand due to increased chronic and infectious diseases, advances in point-of-care testing, and next-generation ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

The emergency department at Rosthern Hospital has been equipped with point-of-care testing technology, a move aimed at ...

The market expansion is primarily fueled by the increasing incidence of venous thromboembolism (VTE), deep vein thrombosis (DVT), pulmonary embolism (PE), and other blood-clotting disorders worldwide.

This eBook explores how innovation and shifting patient expectations are reshaping modern diagnostics—and advancing progress toward global STI elimination goals.

Northwestern scientists have created the fastest-ever hepatitis C diagnostic, delivering accurate results in only 15 minutes. The test uses the DASH rapid PCR system, originally developed for COVID, ...

HighER Level Urgent Care offers CBC testing enabled by CitoCBC®, a CLIA-waived blood analyzer designed for use in ...

The FCA started taking applications. Financial firms can now apply for the regulator's AI Live Testing program, which kicked ...

OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a ...

In alignment with the Government of India’s vision of Aatmanirbhar Bharat and its emphasis on strengthening affordable, accessible, and technology-driven healthcare systems, the Technology ...

A world-first Australian trial shows a simple fingerstick test can accurately detect hepatitis B DNA within an hour ...